Voth E A, Schwartz R H
International Drug Strategy Institute, Topeka, Kansas, USA.
Ann Intern Med. 1997 May 15;126(10):791-8. doi: 10.7326/0003-4819-126-10-199705150-00008.
The use of crude marijuana for herbal medicinal applications is now being widely discussed in both the medical and lay literature. Ballot initiatives in California and Arizona have recently made crude marijuana accessible to patients under certain circumstances. As medicinal applications of pure forms of delta-9-tetrahydrocannabinol (THC) and crude marijuana are being considered, the most promising uses of any form of THC are to counteract the nausea associated with cancer chemotherapy and to stimulate appetite. We evaluated the relevant research published between 1975 and 1996 on the medical applications, physical complications, and legal precedents for the use of pure THC or crude marijuana. Our review focused on the medical use of THC derivatives for nausea associated with cancer chemotherapy, glaucoma, stimulation of appetite, and spinal cord spasticity. Despite the toxicity of THC delivered in any form, evidence supports the selective use of pure THC preparations to treat nausea associated with cancer chemotherapy and to stimulate appetite. The evidence does not support the reclassification of crude marijuana as a prescribable medicine.
目前,在医学文献和大众文献中,关于将未加工的大麻用于草药医学用途的讨论十分广泛。加利福尼亚州和亚利桑那州的投票倡议最近使得在某些情况下患者可以获取未加工的大麻。由于正在考虑将纯形式的δ-9-四氢大麻酚(THC)和未加工的大麻用于医学用途,任何形式的THC最有前景的用途是抵消与癌症化疗相关的恶心感并刺激食欲。我们评估了1975年至1996年间发表的有关使用纯THC或未加工大麻的医学应用、身体并发症及法律先例的相关研究。我们的综述聚焦于THC衍生物在治疗与癌症化疗相关的恶心、青光眼、刺激食欲及脊髓痉挛方面的医学用途。尽管任何形式的THC都具有毒性,但有证据支持选择性地使用纯THC制剂来治疗与癌症化疗相关的恶心并刺激食欲。证据并不支持将未加工的大麻重新归类为可开处方的药物。